These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2114034)

  • 1. Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection.
    Wilson CB; Lewis DB
    Rev Infect Dis; 1990; 12 Suppl 4():S410-20. PubMed ID: 2114034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic basis for increased susceptibility of the neonate to infection.
    Wilson CB
    J Pediatr; 1986 Jan; 108(1):1-12. PubMed ID: 3511202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Listeria monocytogenes specific T-cell lines and clones.
    Kaufmann SH
    Infection; 1988; 16 Suppl 2():S128-36. PubMed ID: 3138185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
    Yap GS; Sher A
    J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent role for TNF-alpha in IFN-gamma-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-gamma receptor 1 deficiency.
    Janssen R; Van Wengen A; Verhard E; De Boer T; Zomerdijk T; Ottenhoff TH; Van Dissel JT
    J Immunol; 2002 Oct; 169(7):3900-7. PubMed ID: 12244188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.
    Wilson CB; Westall J; Johnston L; Lewis DB; Dower SK; Alpert AR
    J Clin Invest; 1986 Mar; 77(3):860-7. PubMed ID: 3081575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii.
    Yamamoto M; Okuyama M; Ma JS; Kimura T; Kamiyama N; Saiga H; Ohshima J; Sasai M; Kayama H; Okamoto T; Huang DC; Soldati-Favre D; Horie K; Takeda J; Takeda K
    Immunity; 2012 Aug; 37(2):302-13. PubMed ID: 22795875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.
    Fehr T; Schoedon G; Odermatt B; Holtschke T; Schneemann M; Bachmann MF; Mak TW; Horak I; Zinkernagel RM
    J Exp Med; 1997 Mar; 185(5):921-31. PubMed ID: 9120398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.
    Murray HW; Rubin BY; Masur H; Roberts RB
    N Engl J Med; 1984 Apr; 310(14):883-9. PubMed ID: 6422299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular defenses against Toxoplasma gondii in newborns.
    Wilson CB; Haas JE
    J Clin Invest; 1984 Jun; 73(6):1606-16. PubMed ID: 6327765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma detection in cultures of newborn cells exposed to Listeria monocytogenes.
    Serushago B; Macdonald C; Lee SH; Stadnyk A; Bortolussi R
    J Interferon Cytokine Res; 1995 Jul; 15(7):633-5. PubMed ID: 7553234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
    Yap GS; Sher A
    Immunobiology; 1999 Dec; 201(2):240-7. PubMed ID: 10631573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interferon system as an integral part of the defense system against infections.
    Kirchner H
    Antiviral Res; 1986 Jan; 6(1):1-17. PubMed ID: 2421640
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular (T cell) immunity in the human newborn.
    Stiehm ER; Winter HS; Bryson YJ
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):814-21. PubMed ID: 159431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
    J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
    Murray HW; Rubin BY; Carriero S; Acosta AM
    J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells undergo rapid ON/OFF but not ON/OFF/ON cycling of cytokine production in response to antigen.
    Corbin GA; Harty JT
    J Immunol; 2005 Jan; 174(2):718-26. PubMed ID: 15634891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.